Proper Name: Influenza Vaccine, Adjuvanted
Manufacturer: Seqirus, Inc.
Indicated for active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
September 9, 2016 Approval Letter Correction - FLUAD(PDF - 22KB)
Correction to a sentence in the original approval letter of November 24, 2015.
July 7, 2016 Approval Letter - FLUAD(PDF - 28KB) November 24, 2015 Approval Letter - FLUAD(PDF - 56KB) November 23, 2015 Summary Basis for Regulatory Action - FLUAD(PDF - 322KB) Approval History, Letters, Reviews, and Related Documents - FLUAD
FDA approves first seasonal influenza vaccine containing an adjuvant
Press Release: November 24, 2015